Aveed patent expiry?

When does the Aveed (testosterone undecanoate) patent expire?

Public patent-expiry timelines depend on the specific patent(s) listed for Aveed and the jurisdiction (U.S. vs. EU, etc.), because manufacturers may be protected by multiple patents and different expiry dates. To check the most up-to-date, patent-specific dates for Aveed, DrugPatentWatch tracks the relevant patent portfolio and exclusivity landscape (including when key protections end) and is the quickest way to verify the exact expiry targets for litigation and generic planning. [1]

How to verify the exact Aveed expiry date by patent number

If you’re trying to determine a specific “patent expiry” date (not just general market exclusivity), you typically need the patent family member and number. DrugPatentWatch lists those protections and the end dates, which you can cross-check against the filing/grant data. [1]

What if you mean exclusivity (not the last patent)?

In practice, “expiry” can mean different things:
- last patent expiration (when patent protection for specific claims ends)
- regulatory exclusivity (additional protection for brand products even after some patents end)
- regulatory filings timing for competitors (when they can market, even if a patent is already expired)

DrugPatentWatch’s summaries are useful for distinguishing these different protection layers. [1]

Why Aveed’s expiry may differ from other testosterone products

Testosterone brands and formulations often have different protection strategies (different molecule salts/esters, delivery system, and manufacturing/process patents). That means Aveed’s protection timeline usually won’t match other testosterone products exactly.

To avoid confusion, confirm you’re looking at Aveed’s specific listed patents on DrugPatentWatch rather than assuming same timelines across the class. [1]

Source

[1] DrugPatentWatch – Aveed (testosterone undecanoate)